Acute increases in plasma mammalian target of rapamycin, glycogen synthase kinase-3β, and eukaryotic elongation factor 2 phosphorylation after ketamine treatment in three depressed patients

Biological Psychiatry

Volumn 73, Issue 12, 2013, Pages

  Yang, Chun ^a   Zhou, Zhi Qiang ^a   Gao, Zhi Qin ^b   Shi, Jin Yun ^a   Yang, Jian Jun ^a  

^a NANJING UNIVERSITY   (China)

^b PLA 102nd Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ELONGATION FACTOR 2; GLYCOGEN SYNTHASE KINASE 3BETA; KETAMINE; MAMMALIAN TARGET OF RAPAMYCIN;

ADULT; ANTIDEPRESSANT ACTIVITY; CASE REPORT; CONTROLLED STUDY; DELIRIUM; DSM-IV-TR; ENZYME BLOOD LEVEL; ENZYME PHOSPHORYLATION; HAMILTON SCALE; HUMAN; LETTER; MAJOR DEPRESSION; MALE; MOLECULAR PATHOLOGY; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSION; EUKARYOTIC INITIATION FACTOR-2; GLYCOGEN SYNTHASE KINASE 3; HUMANS; KETAMINE; MALE; PHOSPHORYLATION; SIROLIMUS; TIME FACTORS; YOUNG ADULT;

EID: 84878395015     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2012.07.022     Document Type: Letter

References (8)

1. R.M. Berman, A. Cappiello, A. Anand, D.A. Oren, G.R. Heninger, and D.S. Charney Antidepressant effects of ketamine in depressed patients Biol Psychiatry 47 2000 351 354
2. R. Machado-Vieira, G. Salvadore, N. Diazgranados, and C.A. Zarate Jr Ketamine and the next generation of antidepressants with a rapid onset of action Pharmacol Ther 123 2009 143 150
3. C.A. Zarate Jr, J.B. Singh, P.J. Carlson, N.E. Brutsche, R. Ameli, and D.A. Luckenbaugh A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression Arch Gen Psychiatry 63 2006 856 864
4. N. Li, B. Lee, R.J. Liu, M. Banasr, J.M. Dwyer, and M. Iwata mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists Science 329 2010 959 964
5. M.C. Denk, C. Rewerts, F. Holsboer, A. Erhardt-Lehmann, and C.W. Turck Monitoring ketamine treatment response in a depressed patient via peripheral mammalian target of rapamycin activation Am J Psychiatry 168 2011 751 752
6. A.E. Autry, M. Adachi, E. Nosyreva, E.S. Na, M.F. Los, and P.F. Cheng NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses Nature 475 2011 91 95
7. E. Beurel, L. Song, and R.S. Jope Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice Mol Psychiatry 16 2011 1068 1070
8. X. Li, and R.S. Jope Is glycogen synthase kinase-3 a central modulator in mood regulation? Neuropsychopharmacology 35 2010 2143 2154